PI3K-mTOR in Cancer and Cancer Therapy
In the post human-genome project era, cancer specific genomic maps are redesigning tumor taxonomy by evolving from histopathology to molecular pathology. The success of a cancer drug today is fundamentally based on the success in identifying target genes that control beneficial pathways. The overwhe...
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | SpringerLink (Online service) |
Otros Autores: | Dey, Nandini (Editor ), De, Pradip (Editor ), Leyland-Jones, Brian (Editor ) |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Cham :
Springer International Publishing : Imprint: Humana,
2016.
|
Edición: | 1st ed. 2016. |
Colección: | Cancer Drug Discovery and Development,
|
Temas: | |
Acceso en línea: | Texto Completo |
Ejemplares similares
-
PARP Inhibitors for Cancer Therapy
Publicado: (2015) -
Resistance to Photodynamic Therapy in Cancer
Publicado: (2015) -
Nitric Oxide and Cancer: Pathogenesis and Therapy
Publicado: (2015) -
Impact of Genetic Targets on Cancer Therapy
Publicado: (2013) -
Mitochondria and Cancer
Publicado: (2009)